{
  "params": {
    "ind": "药品及生物科技",
    "sort": "ygc",
    "page": 1,
    "q": "",
    "sig": false,
    "fcf": "trend",
    "screen": false,
    "big": false,
    "mine": false
  },
  "pages": 1,
  "count": 19,
  "fcf_counts": {
    "all": 170,
    "end": 18,
    "yoy": 3,
    "trend": 19
  },
  "cap_counts": {
    "all": 19,
    "big": 10
  },
  "mine_counts": {
    "all": 19,
    "mine": 0
  },
  "watch_count": 0,
  "watch_updated": null,
  "triggered": 5,
  "details_updated_bj": "2026-10-17 13:54",
  "universe_updated_bj": "2026-10-17 13:49",
  "quotes_updated_bj": "2026-10-17 14:00",
  "quote_source": "腾讯",
  "a_updated_bj": "2026-10-17 14:00",
  "hkd_cny": 0.8517,
  "ah_count": 176,
  "main_period": "2026-06-30",
  "coverage": {
    "2026-06-30": 1995,
    "2025-06-30": 47,
    "2026-03-31": 403,
    "2024-12-31": 15,
    "2026-01-31": 7,
    "2025-12-31": 26,
    "2026-04-30": 15,
    "2025-10-31": 1,
    "2026-02-28": 23,
    "2025-09-30": 4,
    "2025-03-31": 4,
    "2026-09-30": 3,
    "2026-05-31": 8
  },
  "fcf_years": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025"
  ],
  "missing": [],
  "rows": [
    {
      "code": "00950",
      "name": "李氏大药厂",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.055,
      "market_cap_yi": 5.3,
      "ev_yi": 15.5,
      "ee": 14.9,
      "loss": false,
      "ygc": 3.51,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 13.34,
        "cash_yi": 3.16,
        "np_ttm_yi": 1.04,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.4,
          2.4,
          0.7,
          1.8,
          2.5
        ],
        "fcf_avg_yi": 1.7600000000000002,
        "ibd_yi": 2.17,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 18.590000000000003
      },
      "revenue_ttm_yi": 13.55,
      "net_margin": 7.7,
      "roe_by_year": {
        "2023": 0.8427,
        "2024": 5.045,
        "2025": 4.9728
      },
      "roe_avg": 3.62,
      "common_equity_yi": 18.4593,
      "pb": 0.29,
      "roe_pb": 12.61,
      "watched": false
    },
    {
      "code": "02877",
      "name": "神威药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 7.44,
      "market_cap_yi": 52.4,
      "ev_yi": -0.5,
      "ee": -0.1,
      "loss": false,
      "ygc": 2.97,
      "triggered": true,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 22.49,
        "cash_yi": 75.38,
        "np_ttm_yi": 8.04,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          6.1,
          9.8,
          7.9,
          8.2,
          9.7
        ],
        "fcf_avg_yi": 8.34,
        "ibd_yi": 3.12,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 155.66
      },
      "revenue_ttm_yi": 26.64,
      "net_margin": 30.2,
      "roe_by_year": {
        "2023": 14.4516,
        "2024": 11.5856,
        "2025": 12.2347
      },
      "roe_avg": 12.76,
      "common_equity_yi": 82.0615,
      "pb": 0.64,
      "roe_pb": 19.98,
      "watched": false
    },
    {
      "code": "06896",
      "name": "金嗓子",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.905,
      "market_cap_yi": 12,
      "ev_yi": 12.1,
      "ee": 5.6,
      "loss": false,
      "ygc": 1.98,
      "triggered": true,
      "fcf_growth": [
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 9.35,
        "cash_yi": 9.23,
        "np_ttm_yi": 2.15,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.1,
          2.6,
          2.2,
          4.1,
          0.8
        ],
        "fcf_avg_yi": 2.16,
        "ibd_yi": 7.11,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 23.720000000000002
      },
      "revenue_ttm_yi": 9.04,
      "net_margin": 23.8,
      "roe_by_year": {
        "2023": 16.1927,
        "2024": 21.1224,
        "2025": 17.6716
      },
      "roe_avg": 18.33,
      "common_equity_yi": 11.9965,
      "pb": 1,
      "roe_pb": 18.32,
      "watched": false
    },
    {
      "code": "01061",
      "name": "亿胜生物科技",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 2.085,
      "market_cap_yi": 10,
      "ev_yi": 12.3,
      "ee": 5.2,
      "loss": false,
      "ygc": 1.92,
      "triggered": true,
      "fcf_growth": [
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 9.27,
        "cash_yi": 7.01,
        "np_ttm_yi": 2.34,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.3,
          0.9,
          1.9,
          2.3,
          1.2
        ],
        "fcf_avg_yi": 1.52,
        "ibd_yi": 3.03,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 19.18
      },
      "revenue_ttm_yi": 15.2,
      "net_margin": 15.4,
      "roe_by_year": {
        "2023": 15.0615,
        "2024": 15.1808,
        "2025": 14.0227
      },
      "roe_avg": 14.76,
      "common_equity_yi": 22.1416,
      "pb": 0.45,
      "roe_pb": 32.67,
      "watched": false
    },
    {
      "code": "08049",
      "name": "吉林长龙药业",
      "l1": "药品及生物科技",
      "l2": "H股 · 创业板",
      "price": 2.48,
      "market_cap_yi": 11.8,
      "ev_yi": 21,
      "ee": 9.6,
      "loss": false,
      "ygc": 1.86,
      "triggered": true,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 9.23,
        "cash_yi": 0,
        "np_ttm_yi": 2.19,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.2,
          1.9,
          2.8,
          2.1,
          3
        ],
        "fcf_avg_yi": 2.2,
        "ibd_yi": 0.01,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 21.99
      },
      "revenue_ttm_yi": 8.98,
      "net_margin": 24.4,
      "roe_by_year": {
        "2023": 9.5844,
        "2024": 11.8489,
        "2025": 11.988
      },
      "roe_avg": 11.14,
      "common_equity_yi": 18.1127,
      "pb": 0.65,
      "roe_pb": 17.1,
      "watched": false
    },
    {
      "code": "00239",
      "name": "白花油",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 2.39,
      "market_cap_yi": 6.3,
      "ev_yi": 4.4,
      "ee": 5,
      "loss": false,
      "ygc": 1.76,
      "triggered": true,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 1.25,
        "cash_yi": 3.19,
        "np_ttm_yi": 0.87,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0.6,
          0.4,
          1.3,
          0.7,
          1
        ],
        "fcf_avg_yi": 0.8,
        "ibd_yi": 0.12,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 11.07
      },
      "revenue_ttm_yi": 1.95,
      "net_margin": 44.6,
      "roe_by_year": {
        "2023": 14.2676,
        "2024": 10.5042,
        "2025": 12.5591
      },
      "roe_avg": 12.44,
      "common_equity_yi": 6.3755,
      "pb": 0.99,
      "roe_pb": 12.59,
      "watched": false
    },
    {
      "code": "03320",
      "name": "华润医药",
      "l1": "药品及生物科技",
      "l2": "红筹股",
      "price": 4.605,
      "market_cap_yi": 246.4,
      "ev_yi": 995.4,
      "ee": 24,
      "loss": false,
      "ygc": 1.41,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 1749.92,
        "cash_yi": 156.22,
        "np_ttm_yi": 41.55,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          82.2,
          80.8,
          124.2,
          143.3,
          169.3
        ],
        "fcf_avg_yi": 119.96,
        "ibd_yi": 617.64,
        "k": 0.47,
        "k_src": "profit",
        "iv_yi": 346.9446
      },
      "revenue_ttm_yi": 2721.65,
      "net_margin": 1.5,
      "roe_by_year": {
        "2023": 8.6112,
        "2024": 7.1141,
        "2025": 8.1191
      },
      "roe_avg": 7.95,
      "common_equity_yi": 527.9645,
      "pb": 0.47,
      "roe_pb": 17.03,
      "watched": false
    },
    {
      "code": "01099",
      "name": "国药控股",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 15.72,
      "market_cap_yi": 417.8,
      "ev_yi": 1889.8,
      "ee": 26.6,
      "loss": false,
      "ygc": 1.11,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 2680.87,
        "cash_yi": 310.45,
        "np_ttm_yi": 70.93,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          70.5,
          185.5,
          148.4,
          95.8,
          125.2
        ],
        "fcf_avg_yi": 125.08,
        "ibd_yi": 813.16,
        "k": 0.621,
        "k_src": "profit",
        "iv_yi": 464.56388999999996
      },
      "revenue_ttm_yi": 5719.24,
      "net_margin": 1.2,
      "roe_by_year": {
        "2023": 12.6936,
        "2024": 9.1873,
        "2025": 8.788
      },
      "roe_avg": 10.22,
      "common_equity_yi": 851.9406,
      "pb": 0.49,
      "roe_pb": 20.85,
      "watched": false
    },
    {
      "code": "01530",
      "name": "三生制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 14.47,
      "market_cap_yi": 309.7,
      "ev_yi": 290.9,
      "ee": 3.5,
      "loss": false,
      "ygc": 1.05,
      "triggered": false,
      "fcf_growth": [
        "end",
        "yoy",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 48.14,
        "cash_yi": 67.85,
        "np_ttm_yi": 82.71,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          4.3,
          11.6,
          13.8,
          22.4,
          91.3
        ],
        "fcf_avg_yi": 28.679999999999996,
        "ibd_yi": 13.87,
        "k": 0.955,
        "k_src": "profit",
        "iv_yi": 325.44489999999996
      },
      "revenue_ttm_yi": 178.66,
      "net_margin": 46.3,
      "roe_by_year": {
        "2023": 11.4931,
        "2024": 14.1861,
        "2025": 39.781
      },
      "roe_avg": 21.82,
      "common_equity_yi": 275.191,
      "pb": 1.13,
      "roe_pb": 19.39,
      "watched": false
    },
    {
      "code": "01513",
      "name": "丽珠医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 21.26,
      "market_cap_yi": 218.7,
      "ev_yi": 233.9,
      "ee": 14,
      "loss": false,
      "ygc": 1,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 89.94,
        "cash_yi": 73.51,
        "np_ttm_yi": 16.74,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          5.9,
          18.3,
          24.3,
          24.1,
          25.7
        ],
        "fcf_avg_yi": 19.66,
        "ibd_yi": 34.4,
        "k": 0.924,
        "k_src": "profit",
        "iv_yi": 217.79604
      },
      "revenue_ttm_yi": 107.48,
      "net_margin": 15.6,
      "roe_by_year": {
        "2023": 13.9954,
        "2024": 14.7723,
        "2025": 14.5816
      },
      "roe_avg": 14.45,
      "common_equity_yi": 133.6583,
      "pb": 1.64,
      "roe_pb": 8.83,
      "watched": false
    },
    {
      "code": "01681",
      "name": "康臣药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 15.68,
      "market_cap_yi": 111.9,
      "ev_yi": 116.9,
      "ee": 9.9,
      "loss": false,
      "ygc": 0.88,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 17.7,
        "cash_yi": 12.69,
        "np_ttm_yi": 11.75,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          6.3,
          9,
          7.7,
          9.8,
          11.4
        ],
        "fcf_avg_yi": 8.84,
        "ibd_yi": 2.29,
        "k": 0.996,
        "k_src": "profit",
        "iv_yi": 98.4048
      },
      "revenue_ttm_yi": 36.33,
      "net_margin": 32.3,
      "roe_by_year": {
        "2023": 23.1712,
        "2024": 23.5745,
        "2025": 24.9765
      },
      "roe_avg": 23.91,
      "common_equity_yi": 47.6094,
      "pb": 2.35,
      "roe_pb": 10.17,
      "watched": false
    },
    {
      "code": "02161",
      "name": "健倍苗苗",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.6,
      "market_cap_yi": 11.2,
      "ev_yi": 15.5,
      "ee": 8.7,
      "loss": false,
      "ygc": 0.85,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 5.58,
        "cash_yi": 1.06,
        "np_ttm_yi": 1.78,
        "period": "2026-03-31",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0.4,
          1.2,
          1.6,
          1.9,
          1.1
        ],
        "fcf_avg_yi": 1.2399999999999998,
        "ibd_yi": 3.48,
        "k": 0.959,
        "k_src": "profit",
        "iv_yi": 9.570819999999998
      },
      "revenue_ttm_yi": 7.37,
      "net_margin": 24.2,
      "roe_by_year": {
        "2023": 13.3385,
        "2024": 19.2197,
        "2025": 18.6008
      },
      "roe_avg": 17.05,
      "common_equity_yi": 9.537,
      "pb": 1.17,
      "roe_pb": 14.52,
      "watched": false
    },
    {
      "code": "06618",
      "name": "京东健康",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 38.56,
      "market_cap_yi": 1047.8,
      "ev_yi": 1070.5,
      "ee": 17.2,
      "loss": false,
      "ygc": 0.68,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 227.15,
        "cash_yi": 204.46,
        "np_ttm_yi": 62.16,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          29.1,
          36.3,
          45.4,
          43.3,
          101.7
        ],
        "fcf_avg_yi": 51.160000000000004,
        "ibd_yi": 8.75,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 707.3100000000001
      },
      "revenue_ttm_yi": 790.39,
      "net_margin": 7.9,
      "roe_by_year": {
        "2023": 4.5505,
        "2024": 7.9586,
        "2025": 9.324
      },
      "roe_avg": 7.28,
      "common_equity_yi": 614.5611,
      "pb": 1.7,
      "roe_pb": 4.27,
      "watched": false
    },
    {
      "code": "03880",
      "name": "泰德医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 20.4,
      "market_cap_yi": 24.6,
      "ev_yi": 19,
      "ee": 11.2,
      "loss": false,
      "ygc": 0.63,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 2.29,
        "cash_yi": 7.88,
        "np_ttm_yi": 1.69,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0.9,
          0.4,
          0.3,
          1,
          1.4
        ],
        "fcf_avg_yi": 0.8,
        "ibd_yi": 0.31,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 15.57
      },
      "revenue_ttm_yi": 5.51,
      "net_margin": 30.7,
      "roe_by_year": {
        "2023": 21.4331,
        "2024": 20.667,
        "2025": 22.8386
      },
      "roe_avg": 21.65,
      "common_equity_yi": 16.3632,
      "pb": 1.5,
      "roe_pb": 14.4,
      "watched": false
    },
    {
      "code": "01177",
      "name": "中国生物制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 5.25,
      "market_cap_yi": 835.4,
      "ev_yi": 999.3,
      "ee": 41.8,
      "loss": false,
      "ygc": 0.36,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 369.63,
        "cash_yi": 121.24,
        "np_ttm_yi": 23.89,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          35,
          47.2,
          45.9,
          52.2,
          75.9
        ],
        "fcf_avg_yi": 51.24000000000001,
        "ibd_yi": 171.71,
        "k": 0.66,
        "k_src": "profit",
        "iv_yi": 304.8738000000001
      },
      "revenue_ttm_yi": 337.04,
      "net_margin": 7.1,
      "roe_by_year": {
        "2023": 7.7445,
        "2024": 11.2111,
        "2025": 7.4829
      },
      "roe_avg": 8.81,
      "common_equity_yi": 325.6808,
      "pb": 2.57,
      "roe_pb": 3.44,
      "watched": false
    },
    {
      "code": "00241",
      "name": "阿里健康",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 3.005,
      "market_cap_yi": 414,
      "ev_yi": 412,
      "ee": 21.3,
      "loss": false,
      "ygc": 0.34,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 52.37,
        "cash_yi": 54.34,
        "np_ttm_yi": 19.36,
        "period": "2026-03-31",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          4.1,
          2.5,
          10.6,
          13.8,
          12.3
        ],
        "fcf_avg_yi": 8.66,
        "ibd_yi": 0.6,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 140.34
      },
      "revenue_ttm_yi": 342.55,
      "net_margin": 5.7,
      "roe_by_year": {
        "2023": 5.9458,
        "2024": 9.2845,
        "2025": 11.3333
      },
      "roe_avg": 8.85,
      "common_equity_yi": 178.554,
      "pb": 2.32,
      "roe_pb": 3.82,
      "watched": false
    },
    {
      "code": "03692",
      "name": "翰森制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 31.74,
      "market_cap_yi": 1639.3,
      "ev_yi": 1681.1,
      "ee": 25.2,
      "loss": false,
      "ygc": 0.21,
      "triggered": false,
      "fcf_growth": [
        "end",
        "yoy",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 88.37,
        "cash_yi": 46.57,
        "np_ttm_yi": 66.78,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          21,
          24.5,
          27.5,
          33.4,
          62.5
        ],
        "fcf_avg_yi": 33.78,
        "ibd_yi": 42.34,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 342.03000000000003
      },
      "revenue_ttm_yi": 158.99,
      "net_margin": 42,
      "roe_by_year": {
        "2023": 13.5317,
        "2024": 16.0508,
        "2025": 17.3488
      },
      "roe_avg": 15.64,
      "common_equity_yi": 377.6807,
      "pb": 4.34,
      "roe_pb": 3.6,
      "watched": false
    },
    {
      "code": "03347",
      "name": "泰格医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 40.2,
      "market_cap_yi": 411.6,
      "ev_yi": 436.5,
      "ee": 479.7,
      "loss": false,
      "ygc": 0.17,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 48.02,
        "cash_yi": 20.43,
        "np_ttm_yi": 0.91,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          7.9,
          6.8,
          8.4,
          7.4,
          9
        ],
        "fcf_avg_yi": 7.9,
        "ibd_yi": 20.91,
        "k": 0.904,
        "k_src": "profit",
        "iv_yi": 70.98208000000001
      },
      "revenue_ttm_yi": 72.9,
      "net_margin": 1.2,
      "roe_by_year": {
        "2023": 9.9589,
        "2024": 1.9433,
        "2025": 4.2656
      },
      "roe_avg": 5.39,
      "common_equity_yi": 194.7722,
      "pb": 2.11,
      "roe_pb": 2.55,
      "watched": false
    },
    {
      "code": "02607",
      "name": "上海医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 11.17,
      "market_cap_yi": 550.7,
      "ev_yi": 1467,
      "ee": 30.8,
      "loss": false,
      "ygc": 0.09,
      "triggered": false,
      "fcf_growth": [
        "end",
        "yoy",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 1479.84,
        "cash_yi": 322.84,
        "np_ttm_yi": 47.7,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          9.4,
          20.6,
          22.6,
          34.3,
          38.3
        ],
        "fcf_avg_yi": 25.04,
        "ibd_yi": 512.79,
        "k": 0.792,
        "k_src": "profit",
        "iv_yi": 47.8764
      },
      "revenue_ttm_yi": 2894.57,
      "net_margin": 1.6,
      "roe_by_year": {
        "2023": 5.558,
        "2024": 6.4943,
        "2025": 7.7586
      },
      "roe_avg": 6.6,
      "common_equity_yi": 783.4796,
      "pb": 0.7,
      "roe_pb": 9.39,
      "watched": false
    }
  ]
}